Ceapro Inc. develops and utilizes core technologies to supply materials and compounds to the life sciences and personal care and cosmetics industries. The Company discovers, develops, and produces natural health products derived from oats and other grains. Its products include natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides.
Quote | Ceapro Inc (OTCMKTS:CRPOF)
Last: | $0.1845 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1845 |
Close: | $0.1845 |
High: | $0.1845 |
Low: | $0.1845 |
Volume: | 650 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | Ceapro Inc (OTCMKTS:CRPOF)
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that securityholders of both biopharmaceutical devel...
Message Board Posts | Ceapro Inc (OTCMKTS:CRPOF)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CRPOF News Article - Ceapro Inc. Reports Record Financial Results for First Quarter 20 | whytestocks | investorshangout | 05/18/2022 4:20:50 PM |
whytestocks: $CRPOF News Article - Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Vir | whytestocks | investorshangout | 01/08/2021 3:55:49 PM |
CRPOF Daily Chart | Golden Cross | investorshub | 10/16/2019 7:45:41 AM |
$CRPOF Tier_Change: Pink Current to OTCQX International | Golden Cross | investorshub | 10/16/2019 7:44:21 AM |
Too bad there aren't more people here. Great company | ronpopeil | investorshub | 09/29/2016 10:46:22 PM |
News, Short Squeeze, Breakout and More Instantly...
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro ...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that securityholders of both biopharmaceutical devel...